- 商品介绍
- 规格参数
- 包装参数
产品介绍
Product Description
Application
Finasteride has been used:
- as a component of L-15 media to investigate the effects of finasteride exposure on brain, liver and testis tissues
- in culture medium to treat tumor cells in vitro
- as a positive control to treat benign prostatic hyperplasia (BPH)
- to examine its effect on structural and molecular biology on the ventral prostate of senile mice
Biochem/physiol Actions
Finasteride can reduce serum and scalp dihydrotestosterone (DHT) by preventing the transformation of testosterone to DHT. It is usually used to manage benign prostate hyperplasia and pattern hair loss in male. Finasteride possesses androgen-distracting properties.
选择性 5α-还原酶抑制剂;抗雄激素。
技术参数
Specifications
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: soluble >20 mg/mL |
| web metadata keyword.default | ACS grade finasteride,MK-906 finasteride for laboratory use,N-(2-methyl-2-propyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide,finasteride CAS 98319-26-7,finasteride L-15 media component,finasteride SRD5A1 SRD5A2 inhibitors,finasteride Sigma-Aldrich 10mg,finasteride as positive control for BPH,finasteride for DHT reduction studies,finasteride for in vitro tumor cell treatment,finasteride high purity research chemical,finasteride structural biology research,finasteride treatment for senile mice research,finasteride |
| storage temp. | room temp |
| SMILES string | [H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(=O)NC(C)(C)C)[C@@]4(C)CC[C@]3([H])[C@@]1(C)C=CC(=O)N2 |
| InChI | 1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1 |
| InChI key | DBEPLOCGEIEOCV-WSBQPABSSA-N |
| Gene Information | human ... HSD3B1(3283), SRD5A1(6715), SRD5A2(6716) rat ... Hsd3b1(360348), Srd5a1(24950), Srd5a2(64677) |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
猜你喜欢




微信小程序
7X24小时在线咨询